Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
32 results
  • Colorectal Cancer, Melanoma, Lung Cancer, Breast Cancer, Ovarian Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on

  • Colorectal Cancer, Lung Cancer

20-177          Phase I

A First-in-Human, Phase 1a/1b, Open-Label, Dose-Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, and Antitumor Activity of the RAF Dimer Inhibitor BGB-3245 in Patients with Advanced or Refractory Tumors (View details on

  • Breast Cancer, Colorectal Cancer, Ovarian Cancer, Lung Cancer

20-211          Phase I

A Phase 1 Study of SY-5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors (View details on

  • Melanoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer

21-184          Phase I

A Phase 1, First-in-Human Study of DCC-3116 as a Single Agent and in Combination with Trametinib in Patients with Advanced or Metastatic Solid Tumors with RAS or RAF Mutations (View details on

  • Endometrial Cancer, Lung Cancer, Ovarian Cancer, Colorectal Cancer, Breast Cancer

20-444          Phase I

A Phase 1, First-in-human Study of the Safety, Single- and Multiple-Dose Pharmacokinetics, and Preliminary Activity of Escalating Doses of RBN-2397, an Oral PARP7 Inhibitor, in Patients with Solid Tumors (View details on

  • Ovarian Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer

22-235          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of IMM2902 in Patients with HER2-Expressing Advanced Solid Tumors (View details on

  • Ovarian Cancer, Lung Cancer, Endometrial Cancer, Head and Neck Cancer, Colorectal Cancer

21-060          Phase II

A Phase 1/2 Study Evaluating the Safety, Tolerability and Preliminary Antitumor Activity of COM701 in Combination with BMS-986207 (anti-TIGIT antibody) and Nivolumab in Subjects with Advanced Solid Tumors (View details on

  • Colorectal Cancer, Gastric (Stomach) Cancer, Pancreatic Cancer

22-129          Phase II

A Phase 1b/2 Study of Agents Targeting the Mitogen-Activated Protein Kinase Pathway in Patients with Advanced Gastrointestinal Malignancies (HERKULES-3) (View details on

  • Colorectal Cancer

18-144          Phase II

A Phase 2 Study of Dabrafenib and Trametinib in Combination with PDR001 in patients with BRAFV600E metastatic colorectal cancer (View details on

Showing 1 - 10 of 32 results